Mar. 12, 2025 — Neuroscientists have found a link between vocal changes and the aging brain in zebra finch songbirds, which could help lead to earlier diagnoses for disorders such as Parkinson's ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

Effect of Acupressure on the Blood Pressure, Heart Rate, and Pain Severity of Patients who Underwent Coronary Angiography: A Randomized Controlled Trial. Evaluate the Safety and Efficacy of a ...

CNM-Au8 prolonged survival for people with ALS relative to those who received the investigational treatment zilucoplan or a ...

为探究 EDB 潜在神经保护机制，研究人员构建模型研究其影响，发现 EDB 改善相关损伤，提供新依据。 依达拉奉葡萄糖（Edaravone dextrose，EDB）因其抗炎和清除自由基的特性，是临床常用的脑梗死治疗药物。然而，其潜在的额外神经保护机制仍有待进一步探究。

Despite the best efforts of drug developers, just a handful of disease-modifying drugs, such as Mitsubishi Tanabe's Radicava (edaravone) and generic drug riluzole, have been approved for ALS ...

The demise of Relyvrio is a big blow to the ALS patient community, as the drug was only the third to be approved by the FDA for the disease after Mitsubishi Tanabe’s Radicava (edaravone ...